Psoriasis with insufficient response to first-line csDMARD in a young patient

This patient case has been developed with the assistance of Professor Dennis McGonagle (NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom).

The information presented is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of their professional license, experience, and knowledge of the individual patient.

For full prescribing information, including indications, contraindications, warnings, precautions, and adverse events, please refer to the approved product labeling. Please note that products may have different product labeling according to geographical location. In Europe, full prescribing information is available from the European Medicines Agency (ema.europa.eu).

All characters and events depicted in this patient case simulation are entirely fictitious. Any similarity to actual events or persons, living or dead, is purely coincidental. This activity is intended for healthcare professionals (HCPs) registered to practice in Europe. To proceed, please confirm that you are a HCP practicing in Europe.

Modules

• Psoriasis with insufficient response to first-line csDMARD in a young patient

• A 46-year-old man with psoriasis and new-onset joint disease